Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Exploring the genetics of lithium response in bipolar disorders

    Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP. It also has bee...

    Marisol Herrera-Rivero, Mazda Adli in International Journal of Bipolar Disorders (2024)

  2. Article

    Open Access

    Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study

    Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study...

    Anna H. Ou, Sara B. Rosenthal, Mazda Adli, Kazufumi Akiyama in Translational Psychiatry (2024)

  3. Article

    Open Access

    Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis

    Lithium (Li) is one of the most effective drugs for treating bipolar disorder (BD), however, there is presently no way to predict response to guide treatment. The aim of this study is to identify functional ge...

    Vipavee Niemsiri, Sara Brin Rosenthal, Caroline M. Nievergelt in Molecular Psychiatry (2024)

  4. No Access

    Article

    Genome-wide significant risk loci for mood disorders in the Old Order Amish founder population

    Genome-wide association studies (GWAS) of mood disorders in large case-control cohorts have identified numerous risk loci, yet pathophysiological mechanisms remain elusive, primarily due to the very small effe...

    Elizabeth M. Humphries, Kwangmi Ahn, Rachel L. Kember in Molecular Psychiatry (2023)

  5. Article

    Open Access

    Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

    Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not consiste...

    Azmeraw T. Amare, Anbupalam Thalamuthu, Klaus Oliver Schubert in Molecular Psychiatry (2023)

  6. Article

    Open Access

    Investigating the phenotypic and genetic associations between personality traits and suicidal behavior across major mental health diagnoses

    Personality traits influence risk for suicidal behavior. We examined phenotype- and genotype-level associations between the Big Five personality traits and suicidal ideation and attempt in major depressive, bi...

    Janos L. Kalman, Tomoya Yoshida in European Archives of Psychiatry and Clinic… (2022)

  7. No Access

    Article

    Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder

    Bipolar disorder is an often-severe mental health condition characterized by alternation between extreme mood states of mania and depression. Despite strong heritability and the recent identification of 64 com...

    Naushaba Hasin, Lace M. Riggs, Tatyana Shekhtman, Justin Ashworth in Molecular Psychiatry (2022)

  8. Article

    Open Access

    Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

    Klaus Oliver Schubert, Anbupalam Thalamuthu, Azmeraw T. Amare in Translational Psychiatry (2022)

  9. No Access

    Article

    Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia

    We report results from the Bipolar Exome (BipEx) collaboration analysis of whole-exome sequencing of 13,933 patients with bipolar disorder (BD) matched with 14,422 controls. We find an excess of ultra-rare pro...

    Duncan S. Palmer, Daniel P. Howrigan, Sinéad B. Chapman, Rolf Adolfsson in Nature Genetics (2022)

  10. No Access

    Article

    Amygdala and anterior cingulate transcriptomes from individuals with bipolar disorder reveal downregulated neuroimmune and synaptic pathways

    Recent genetic studies have identified variants associated with bipolar disorder (BD), but it remains unclear how brain gene expression is altered in BD and how genetic risk for BD may contribute to these alte...

    Peter P. Zandi, Andrew E. Jaffe, Fernando S. Goes, Emily E. Burke in Nature Neuroscience (2022)

  11. Article

    Open Access

    Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

    Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs widely between individuals. The molecular mechanisms underlying treatment response heterogeneity are not well unders...

    Klaus Oliver Schubert, Anbupalam Thalamuthu, Azmeraw T. Amare in Translational Psychiatry (2021)

  12. Article

    Open Access

    HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders

    Bipolar affective disorder (BD) is a severe psychiatric illness, for which lithium (Li) is the gold standard for acute and maintenance therapies. The therapeutic response to Li in BD is heterogeneous and relia...

    Sigrid Le Clerc, Laura Lombardi, Bernhard T. Baune, Azmeraw T. Amare in Scientific Reports (2021)

  13. Article

    Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder

    A Correction to this paper has been published: https://doi.org/10.1038/s41380-021-01063-8

    **aoming Jia, Fernando S. Goes, Adam E. Locke, Duncan Palmer in Molecular Psychiatry (2021)

  14. Article

    Open Access

    Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder

    Bipolar disorder (BD) is a serious mental illness with substantial common variant heritability. However, the role of rare coding variation in BD is not well established. We examined the protein-coding (exonic)...

    **aoming Jia, Fernando S. Goes, Adam E. Locke, Duncan Palmer in Molecular Psychiatry (2021)

  15. No Access

    Article

    De novo variation in bipolar disorder

    Bipolar disorder (BD) is a common, highly heritable disorder that affects 1–2% of the world’s population. To date, most genetic studies of BD have focused on common gene variation, and while robustly associate...

    Fernando S. Goes, Mehdi Pirooznia, Martin Tehan, Peter P. Zandi in Molecular Psychiatry (2021)

  16. No Access

    Article

    Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies

    Bipolar disorder (BD) is a neuropsychiatric illness defined by recurrent episodes of mania/hypomania, depression and circadian rhythm abnormalities. Lithium is an effective drug for BD, but 30–40% of patients ...

    Himanshu K. Mishra, Noelle M. Ying, Angelica Luis, Heather Wei in Molecular Psychiatry (2021)

  17. No Access

    Article

    Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

    Lithium is a first-line medication for bipolar disorder (BD), but only one in three patients respond optimally to the drug. Since evidence shows a strong clinical and genetic overlap between depression and bip...

    Azmeraw T. Amare, Klaus Oliver Schubert, Li** Hou, Scott R. Clark in Molecular Psychiatry (2021)

  18. No Access

    Article

    Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Bipolar disorder is a heritable mental illness with complex etiology. We performed a genome-wide association study of 41,917 bipolar disorder cases and 371,549 controls of European ancestry, which identified 6...

    Niamh Mullins, Andreas J. Forstner, Kevin S. O’Connell, Brandon Coombes in Nature Genetics (2021)

  19. No Access

    Chapter and Conference Paper

    Develo** Treatments for Alzheimer’s and Related Disorders with Precision Medicine: A Vision

    Precision medicine, also known as personalized medicine, is concerned with finding the right treatment for the right patient at the right time. It is a way of thinking focused on parsing heterogeneity ultimate...

    Dimitrios Avramopoulos, Dimitrios Kapogiannis, Jeannie-Marie Leoutsakos in GeNeDis 2020 (2021)

  20. Article

    Open Access

    lncRNAKB, a knowledgebase of tissue-specific functional annotation and trait association of long noncoding RNA

    Long non-coding RNA Knowledgebase (lncRNAKB) is an integrated resource for exploring lncRNA biology in the context of tissue-specificity and disease association. A systematic integration of annotations from si...

    Fayaz Seifuddin, Komudi Singh, Abhilash Suresh, Jennifer T. Judy in Scientific Data (2020)

previous disabled Page of 2